No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Expert Data Scientist David Lamitina, PhD, Joins Perspecta

Editor: What To Know

  •  From working in both large and small companies, both insider and in service of public education and healthcare, Lamitina has a rich background of experiences that help him appreciate the similarities and differences in how actors want to make use of data.
  • “We have a large and ever-growing collection of provider data that few, if any, organization possesses and we have a long history of taking raw, unverified data and transforming it for accuracy and meaningful application.
  • Lamitina will further advance Perspecta’s product roadmap by designing data-driven solutions, developing meaningful products, delivering on customer-centric projects, and presenting data in an intuitive, meaningful way for better decision-making and user experience.

Perspecta announced David Lamitina, Ph.D., has been added to its growing product team. Lamitina will join the company as a new Senior Data Scientist, with over 15 years of experience as a strategic technology leader.

Lamitina received his Ph.D. from the University of Nevada, Reno in Counseling and Educational Psychology. Most of his impressive career path focused around building longitudinal data systems, measuring learning, and modeling growth. From working in both large and small companies, both insider and in service of public education and healthcare, Lamitina has a rich background of experiences that help him appreciate the similarities and differences in how actors want to make use of data.

“There are two critical opportunities that drew me to Perspecta, which I believe are key to incorporating actionable Machine Learning into everyday business processes,” Lamitina says. “We have a large and ever-growing collection of provider data that few, if any, organization possesses and we have a long history of taking raw, unverified data and transforming it for accuracy and meaningful application.”

Jeff Wen, VP of Product Management, is excited about the level of knowledge and expertise that Lamitina brings to Perspecta.

“David has proven success in delivering data-driven applications and managing large-scale programs,” Wen says. “David will play a major role in leading Perspecta’s proprietary data-cleansing process via machine learning and solidifying our data analytics strategy, which will positively impact the dozens of Perspecta customers who already benefit from our data-cleansing solutions.”

Dr. Lamitina will further advance Perspecta’s product roadmap by designing data-driven solutions, developing meaningful products, delivering on customer-centric projects, and presenting data in an intuitive, meaningful way for better decision-making and user experience.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy